IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Mime-Version:
1.0
Sender:
Information and Referral and Internet Sightings <[log in to unmask]>
Subject:
news byte: AstraZeneca and UT Southwestern Medical Center Collaborate
From:
Sylvia Caras <[log in to unmask]>
Date:
Mon, 1 Oct 2007 11:22:47 -0700
Content-Type:
text/plain; charset=us-ascii; format=flowed; x-avg-checked=avg-ok-40D1656
Reply-To:
[log in to unmask]
Parts/Attachments:
text/plain (13 lines) 
 From PR Newswire - Sep 24, 2007
WILMINGTON, Del., and DALLAS, September 24, 2007 
/PRNewswire-FirstCall/ -- Depression is one of the leading causes of 
disability in the United States, affecting approximately 14.8 million 
adults or about 6.7 percent of the population age 18 and older in a 
given year. To address this growing problem, AstraZeneca today 
announced that it will collaborate with the University of Texas 
Southwestern Medical Center to accelerate scientific discovery and 
therapeutic advancement for depression.


"People Who experience mood swings, fear, voices and visions"

ATOM RSS1 RSS2